Suppr超能文献

宁波市新生儿乙肝免疫预防策略的卫生经济学评价:一项马尔可夫模型研究

Health economic evaluation of newborn hepatitis B immunization prevention strategies in Ningbo: a Markov modeling study.

作者信息

Feng Wei, Li Zhengxiong, Fan Mingkuan, Yang Sijia, Shao Yuqi, Liu Kui, Huang Shuaishuai, Fu Sanjun

机构信息

Fenghua District Center for Disease Control and Prevention, Ningbo, China.

School of Medical Informatics and Engineering, Xuzhou Medical University, Xuzhou, China.

出版信息

Front Public Health. 2025 Apr 16;13:1532604. doi: 10.3389/fpubh.2025.1532604. eCollection 2025.

Abstract

BACKGROUND

Hepatitis B virus (HBV) infection poses a significant public health challenge in China. The Prevention of mother-to-child Transmission (PMTCT) strategy of combining universal hepatitis B vaccination with hepatitis B immunoglobulin (HBIG) for newborns is crucial in preventing widespread infection. In this study, we conduct health economic evaluation of three strategies: PMTCT, universal vaccination, and non-vaccination for newborns in Ningbo, China.

METHODS

This study developed a decision-Markov model and simulated a cohort of 100,000 newborns to assess the cost-effectiveness and cost-benefit of three strategies from a healthcare system perspective. The primary outputs included total costs, life-years (LYs), quality-adjusted life-years (QALYs), incremental cost-effectiveness ratios (ICERs), benefit-cost ratios (BCRs). One-way and probabilistic sensitivity analyses (PSA) were performed to verify the robustness of the model.

RESULTS

Among the three strategies, the PMTCT results in the least disease burden and mortality related to hepatitis B. In comparison to a cohort of 100,000 unvaccinated infants, the PMTCT is expected to prevent 6,029 cases of acute symptomatic infections, 27,348 HBV carriers, 4,170 chronic infections, 3,597 cases of cirrhosis, 2,911 cases of hepatocellular carcinoma (HCC), and 3,930 HBV-related deaths. The ICERs for PMTCT and universal vaccination were - 56,371.77 yuan/QALY and - 56,654.77 yuan/QALY, respectively. The BCRs for PMTCT and universal vaccination were 19.13 and 15.95, respectively, when compared to no vaccination. The PSA revealed that all ICER scatter points are situated within the fourth quadrant, and the probability of PMTCT being cost-effective exceeds 90%.

CONCLUSION

Implementing universal hepatitis B vaccination with HBIG for newborns in Ningbo demonstrated high cost-effectiveness, making the continuation of the PMTCT strategy highly recommended.

摘要

背景

乙型肝炎病毒(HBV)感染给中国带来了重大的公共卫生挑战。将新生儿普遍接种乙肝疫苗与乙肝免疫球蛋白(HBIG)相结合的母婴传播预防(PMTCT)策略对于预防广泛感染至关重要。在本研究中,我们对中国宁波的三种策略进行了卫生经济学评估:PMTCT、普遍接种疫苗和新生儿不接种疫苗。

方法

本研究建立了一个决策马尔可夫模型,并模拟了100,000名新生儿队列,从医疗保健系统的角度评估三种策略的成本效益和成本效益。主要产出包括总成本、生命年(LYs)、质量调整生命年(QALYs)、增量成本效益比(ICERs)、效益成本比(BCRs)。进行了单向和概率敏感性分析(PSA)以验证模型的稳健性。

结果

在这三种策略中,PMTCT导致的与乙肝相关的疾病负担和死亡率最低。与100,000名未接种疫苗的婴儿队列相比,预计PMTCT可预防6,029例急性症状性感染、27,348例HBV携带者、4,170例慢性感染、3,597例肝硬化、2,911例肝细胞癌(HCC)和3,930例HBV相关死亡。PMTCT和普遍接种疫苗的ICER分别为-56,371.77元/QALY和-56,654.77元/QALY。与不接种疫苗相比,PMTCT和普遍接种疫苗的BCR分别为19.13和15.95。PSA显示所有ICER散点均位于第四象限,PMTCT具有成本效益的概率超过90%。

结论

在宁波对新生儿实施普遍接种乙肝疫苗联合HBIG显示出高成本效益,强烈建议继续实施PMTCT策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e14/12040845/eb86be1bf93d/fpubh-13-1532604-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验